Showing 13,021 - 13,040 results of 32,904 for search '(( 50 ((teer decrease) OR (a decrease)) ) OR ( 5 ((non decrease) OR (mean decrease)) ))', query time: 0.74s Refine Results
  1. 13021

    Image_5_T2DM may exert a protective effect against digestive system tumors in East Asian populations: a Mendelian randomization analysis.tif by Ni An (511459)

    Published 2024
    “…</p>Results<p>T2DM is associated with a reduced risk of esophageal (OR: 0.77, 95% CI: 0.71 to 0.83, P< 0.001), gastric (OR: 0.87, 95% CI: 0.84 to 0.90, P< 0.001) and colorectal cancer (OR: 0.88, 95% CI: 0.85 to 0.91, P< 0.001) and hepatocellular carcinoma (OR: 0.92, 95% CI: 0.86 to 0.97, P = 0.005) and an increased risk of pancreatic cancer (OR: 1.92, 95% CI: 1.47 to 2.50, P< 0.001) in East Asian population. …”
  2. 13022

    Data_Sheet_1_Characterization of a Novel Functional Trimeric Catechol 1,2-Dioxygenase From a Pseudomonas stutzeri Isolated From the Gulf of Mexico.docx by Julieta Rodríguez-Salazar (8931386)

    Published 2020
    “…The purified PsC12DO enzyme was found as an active trimer, with a molecular mass of 107 kDa. Increasing NaCl concentration in the enzyme reaction gradually reduced activity; in high salt concentrations (0.7 M NaCl) quaternary structural analysis determined that the enzyme changes to a dimeric arrangement and causes a 51% decrease in specific activity on catechol substrate. …”
  3. 13023

    Image_2_T2DM may exert a protective effect against digestive system tumors in East Asian populations: a Mendelian randomization analysis.tiff by Ni An (511459)

    Published 2024
    “…</p>Results<p>T2DM is associated with a reduced risk of esophageal (OR: 0.77, 95% CI: 0.71 to 0.83, P< 0.001), gastric (OR: 0.87, 95% CI: 0.84 to 0.90, P< 0.001) and colorectal cancer (OR: 0.88, 95% CI: 0.85 to 0.91, P< 0.001) and hepatocellular carcinoma (OR: 0.92, 95% CI: 0.86 to 0.97, P = 0.005) and an increased risk of pancreatic cancer (OR: 1.92, 95% CI: 1.47 to 2.50, P< 0.001) in East Asian population. …”
  4. 13024

    Image_4_T2DM may exert a protective effect against digestive system tumors in East Asian populations: a Mendelian randomization analysis.tif by Ni An (511459)

    Published 2024
    “…</p>Results<p>T2DM is associated with a reduced risk of esophageal (OR: 0.77, 95% CI: 0.71 to 0.83, P< 0.001), gastric (OR: 0.87, 95% CI: 0.84 to 0.90, P< 0.001) and colorectal cancer (OR: 0.88, 95% CI: 0.85 to 0.91, P< 0.001) and hepatocellular carcinoma (OR: 0.92, 95% CI: 0.86 to 0.97, P = 0.005) and an increased risk of pancreatic cancer (OR: 1.92, 95% CI: 1.47 to 2.50, P< 0.001) in East Asian population. …”
  5. 13025

    Image_1_T2DM may exert a protective effect against digestive system tumors in East Asian populations: a Mendelian randomization analysis.tif by Ni An (511459)

    Published 2024
    “…</p>Results<p>T2DM is associated with a reduced risk of esophageal (OR: 0.77, 95% CI: 0.71 to 0.83, P< 0.001), gastric (OR: 0.87, 95% CI: 0.84 to 0.90, P< 0.001) and colorectal cancer (OR: 0.88, 95% CI: 0.85 to 0.91, P< 0.001) and hepatocellular carcinoma (OR: 0.92, 95% CI: 0.86 to 0.97, P = 0.005) and an increased risk of pancreatic cancer (OR: 1.92, 95% CI: 1.47 to 2.50, P< 0.001) in East Asian population. …”
  6. 13026

    Image_3_T2DM may exert a protective effect against digestive system tumors in East Asian populations: a Mendelian randomization analysis.tif by Ni An (511459)

    Published 2024
    “…</p>Results<p>T2DM is associated with a reduced risk of esophageal (OR: 0.77, 95% CI: 0.71 to 0.83, P< 0.001), gastric (OR: 0.87, 95% CI: 0.84 to 0.90, P< 0.001) and colorectal cancer (OR: 0.88, 95% CI: 0.85 to 0.91, P< 0.001) and hepatocellular carcinoma (OR: 0.92, 95% CI: 0.86 to 0.97, P = 0.005) and an increased risk of pancreatic cancer (OR: 1.92, 95% CI: 1.47 to 2.50, P< 0.001) in East Asian population. …”
  7. 13027

    Table_1_T2DM may exert a protective effect against digestive system tumors in East Asian populations: a Mendelian randomization analysis.xlsx by Ni An (511459)

    Published 2024
    “…</p>Results<p>T2DM is associated with a reduced risk of esophageal (OR: 0.77, 95% CI: 0.71 to 0.83, P< 0.001), gastric (OR: 0.87, 95% CI: 0.84 to 0.90, P< 0.001) and colorectal cancer (OR: 0.88, 95% CI: 0.85 to 0.91, P< 0.001) and hepatocellular carcinoma (OR: 0.92, 95% CI: 0.86 to 0.97, P = 0.005) and an increased risk of pancreatic cancer (OR: 1.92, 95% CI: 1.47 to 2.50, P< 0.001) in East Asian population. …”
  8. 13028
  9. 13029

    Global Land Use Change Impacts on Soil Nitrogen Availability and Environmental Losses by Jing Wang (6206297)

    Published 2025
    “…Anthropogenic activities, particularly land use change and management practices, alter the global nitrogen (N) cycle. As a central part of the global N cycle, soil N supply from net N mineralization (NNM) and net nitrification (NN) contributes to over 50% of crop N uptake. …”
  10. 13030
  11. 13031

    Predictors in ordinal regression model for GDS. by Shane Naidoo (20148021)

    Published 2025
    “…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m<sup>2</sup> (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”
  12. 13032

    Classification of hand grip strength. by Shane Naidoo (20148021)

    Published 2025
    “…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m<sup>2</sup> (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”
  13. 13033

    Rating scale for functional severity [28]. by Shane Naidoo (20148021)

    Published 2025
    “…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m<sup>2</sup> (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”
  14. 13034

    Regression model coefficients. by Shane Naidoo (20148021)

    Published 2025
    “…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m<sup>2</sup> (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”
  15. 13035

    ICOPE screening positive participant’s responses. by Shane Naidoo (20148021)

    Published 2025
    “…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m<sup>2</sup> (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”
  16. 13036

    WHO BMI classification for adults. by Shane Naidoo (20148021)

    Published 2025
    “…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m<sup>2</sup> (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”
  17. 13037
  18. 13038

    Primary data set used for analysis. by Louis Lambrechts (241741)

    Published 2023
    “…In addition, transmission probability was influenced by the day of illness in a non-monotonic fashion; i.e., transmission probability increased until 2 days after symptom onset and decreased thereafter. …”
  19. 13039

    Mkrn1 interacts strongly with the poly(A) binding protein. by Annabelle Dold (7532576)

    Published 2020
    “…<p>(A) Western blot analysis of co-IP experiments between Venus-Mkrn1 and pAbp. α-Tubulin (lanes 1, 2) and ovaries lacking the Venus-Mkrn1 transgene (lane 4) were used as negative controls. …”
  20. 13040